Skip to main content
. 2020 Dec 15;8(4):E887–E894. doi: 10.9778/cmajo.20200191

Table 5:

Performance of the symptom screening tool (sensitivity analysis)*

SARS-CoV-2 positive SARS-CoV-2 negative Total
Screening positive 71 1490 1561
Screening negative 6 1808 1814
Total 77 3298 3375
Point estimates (95% CI)
Apparent prevalence 0.46 (0.45–0.48)
True prevalence 0.02 (0.02–0.03)
Accuracy 0.56 (0.54–0.57)
Sensitivity 0.92 (0.84–0.97)
Specificity 0.55 (0.53–0.56)
Positive predictive value 0.04 (0.04–0.06)
Negative predictive value 0.997 (0.993–0.998)
Positive likelihood ratio 2.04 (1.89–2.20)
Negative likelihood ratio 0.14 (0.07–0.31)
Odds ratio 14.36 (6.22–33.13)

Note: CI = confidence interval, SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.

*

Assuming asymptomatic prevalence = 0.0035 (6 people with SARS-CoV-2 infection among 1814 without symptoms).